Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MannKind
MannKind
Here's Why MannKind Corporation Remained Stuck in Reverse and Lost 24% in February
Motley Fool
Sun, 03/12/17 - 10:51 am
MannKind
diabetes
inhaled insulin
Afrezza
Can MannKind Be Saved?
Barron's
Tue, 02/28/17 - 11:25 am
MannKind
Afrezza
diabetes
inhaled insulin
MannKind Attempts to Revive Afrezza Sales
Investopedia
Fri, 02/3/17 - 11:21 am
MannKind
Afrezza
diabetes
inhaled insulin
Afrezza Sales Still Low As MannKind Prepares For Investor Update
Seeking Alpha
Sat, 01/28/17 - 02:32 pm
Afrezza
MannKind
diabetes
inhaled insulin
MannKind: Afrezza Sales Start Off 2017 Modestly. Will A Bigger Sales Force Make A Material Difference?
Seeking Alpha
Tue, 01/17/17 - 10:22 pm
MannKind
Afrezza
diabetes
drug reps
inhaled insulin
JPM: Day 4 round-up
BioPharma Dive
Fri, 01/13/17 - 12:09 pm
JPMHC 2017
Novavax
Tesaro
MannKind
MannKind's $1M Milestone: Good News, But Barely
Seeking Alpha
Wed, 01/4/17 - 10:41 am
MannKind
diabetes
Receptor Life Sciences
MannKind Receives $1 Million Milestone From RLS
Yahoo
Tue, 01/3/17 - 09:50 am
MannKind
Receptor Life Sciences
Mannkind's Afrezza Is Fizzling Out
Seeking Alpha
Mon, 01/2/17 - 11:58 am
MannKind
Afrezza
diabetes
inhaled insulin
2 Key Reasons MannKind Needs To Remain On Nasdaq
Seeking Alpha
Wed, 11/30/16 - 09:57 am
MannKind
diabetes
NASDAQ
Afrezza
MannKind - Afrezza Scripts Still Low As Year-End Holidays Approach
Seeking Alpha
Mon, 11/28/16 - 11:40 pm
MannKind
Afrezza
diabetes
inhaled insulin
MannKind's Afrezza Sales Remain Below 300 Scripts - Can The Company Increase Sales Soon?
Seeking Alpha
Tue, 11/22/16 - 11:23 am
MannKind
Afrezza
diabetes
inhaled insulin
Sanofi Took $100M Hit on MannKind Deal
Investopedia
Sat, 11/12/16 - 04:35 pm
Sanofi
MannKind
Afrezza
diabetes
inhaled insulin
MannKind, Sanofi Reach Agreement on AFREZZA; Sanofi to Purchase $10.2M Worth of Insulin from MannKind
Yahoo/Benzinga
Thu, 11/10/16 - 12:28 pm
MannKind
Sanofi
Afrezza
inhaled insulin
diabetes
MannKind: Afrezza Sales Fizzle Going Into Quarterly Call
Seeking Alpha
Sat, 11/5/16 - 02:08 pm
MannKind
Afrezza
diabetes
inhaled insulin
earnings
These 2 Biotechs Could Vanish by 2018
Motley Fool
Fri, 10/7/16 - 08:57 am
biotech
Acadia
MannKind
Nuplazid
Afrezza
Can MannKind Compete Against Mylan's EpiPen?
Investopedia
Tue, 09/27/16 - 09:57 am
MannKind
Mylan
EpiPen
MannKind - Take A Deep Breath, Afrezza Sales Numbers Are Tough To Swallow
Seeking Alpha
Tue, 09/20/16 - 08:36 pm
MannKind
Afrezza
inhaled insulin
diabetes
Mylan may get the 'horns' from EpiPen competitors as pricing controversy burns hot
Fierce Pharma
Tue, 09/6/16 - 12:43 pm
Mylan Labs
EpiPen
drug pricing
Teva Pharmaceutical
Impax Labs
MannKind
MannKind - 2 Months Into Relaunch Of Afrezza - Where Things Stand And What To Expect
Seeking Alpha
Fri, 09/2/16 - 10:26 pm
MannKind
Afrezza
diabetes
drug launches
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »